Transaction DateRecipientSharesTypePriceValue
30th September 2020Ronald B Sr Kalich459Grant/award etc.$38.91$17,859.69
30th September 2020David Dantzker417Grant/award etc.$38.91$16,225.47
22nd September 2020Joseph J. Stich1,300Bona fide gift$0.00
1st September 2020Gary R Maharaj3,000Open or private sale$45.07$135,206.40
19th August 2020Joseph J. Stich2,500Open or private sale$46.71$116,780.75
7th August 2020Lisa Wipperman Heine1,200Open or private sale$18.03$21,636.00
3rd August 2020Gary R Maharaj3,000Open or private sale$47.44$142,333.80
22nd July 2020Joseph J. Stich9,418Payment by withholding$44.97$423,527.46
22nd July 2020Joseph J. Stich12,612Exercise of derivative$22.58$284,778.96
17th July 2020Timothy J. Arens95Payment by withholding$45.34$4,307.30
Sur Modics
Sur Modics logo

Based on disclosure changes, sentiment, insider trading and news impact we give a rating of 10/10.


SurModics, Inc. engages in the provision of medical device and in vitro diagnostic technologies to the healthcare industry. It operates through Medical Device and In Vitro Diagnostics segments. The Medical Device segment designs, develops, and manufactures interventional medical devices, surface modification coating technologies, as well as drug-delivery coating technologies. The In Vitra Diagnostics segment consists of component products and technologies for diagnostic test kits and biomedical research applications.


Ticker: SRDX
Sector: Health Technology
Industry: Medical Specialties
SEC Central Index Key (CIK): 924717
Employees: 369
Exchange: NASDAQ
Auditor Opinion:

Disclosure Language changes
Red Flags
Fundamentals
Cash at Carrying Value: $36 M (19%)
Inventory, Net: $6 M (0%)
Assets, Current: $88 M (7%)
Property, Plant and Equipment, Net: $29 M (-2%)
Other Assets, Noncurrent: $5 M (0%)
Assets: $166 M (4%)
Accounts Payable, Current: $1 M (-34%)
Liabilities, Current: $16 M (-22%)
Other Liabilities, Noncurrent: $8 M (42%)
Liabilities: $36 M (-3%)
Common Stock, Value, Issued: $682 Th (1%)
Common Stock, Shares, Issued: $14 M (1%)
Additional Paid in Capital, Common Stock: $14 M (27%)
Retained Earnings (Accumulated Deficit): $115 M (3%)
Accumulated Other Comprehensive Income (Loss), Net of Tax: $1 M (270%)
Stockholders' Equity (Parent): $131 M (0%)
Liabilities and Equity: $166 M (4%)
Revenue: $27 M (0%)
Cost of Revenue: $4 M (-61%)
Operating Income/Loss: $1 M (0%)
Other Income, net: $47 Th (-60%)
Provision for income taxes: $1 M (4%)
EPS (basic): $0.18 (-40%)
EPS (diluted): $0.18 (-40%)